Results 21 to 30 of about 4,568 (118)
Journal of Diabetes, Volume 14, Issue 11, Page 758-766, November 2022., 2022 Highlights Diabetic ketoacidosis rate and HbA1c were not elevated in pediatric patients with type 1 diabetes mellitus (T1DM) and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. Pediatric patients with known T1DM did not show an elevated COVID‐19 manifestation index; only pediatric patients with coincident SARS‐CoV‐2 infection ...
Bastian Raphael Büttner +9 more
wiley +1 more source
Journal of Diabetes, Volume 14, Issue 9, Page 606-619, September 2022., 2022 Highlights To what extent NAFLD is associated with glycemic remission among the general population remains unclear. The study elaborated that presence of NAFLD and fibrosis status decreased the chance of glycemic remission whereas NAFLD improvement mitigated glycemic deterioration, emphasizing joint management to liver‐focused subgroups of diabetes ...
Zhuojun Xin +15 more
wiley +1 more source
Journal of Diabetes, Volume 14, Issue 9, Page 620-629, September 2022., 2022 Highlights Body composition changes were identified by baseline thyroid‐stimulating hormone (TSH) and difference in TSH (∆TSH) levels. A positive correlation between ∆TSH and ∆glucose was established. Patients with high TSH levels in the euthyroid state need muscle and fat management.
Hyunah Kim +5 more
wiley +1 more source
Journal of Diabetes, Volume 14, Issue 7, Page 476-484, July 2022., 2022 Highlights The accordance between the paired dataset between FSL and iPro2 was acceptable but poorer in hypoglycemic range. Significant differences for glycemic metrics between iPro2 and FSL were observed in time in range 70–180 mg/dL, coefficient of variation, and hypoglycemia‐related parameters (including time below range 54 mg/dL and 70mg/dL).
Yongwen Zhou +9 more
wiley +1 more source
Journal of Diabetes, Volume 14, Issue 6, Page 401-413, June 2022., 2022 Highlights Insulin degludec/liraglutide (IDegLira) has good efficacy and tolerability in Chinese adults with type 2 diabetes not controlled on oral antidiabetic drugs. IDegLira provides the clinical advantages of insulin and glucagon‐like peptide 1 receptor agonists, improving glycemic control while reducing the main adverse effects of insulin (weight ...
Weiqing Wang +11 more
wiley +1 more source
Effect of type 2 diabetes on A disintegrin and metalloprotease 10 2型糖尿病对解整合素金属蛋白酶10表达的影响
Journal of Diabetes, Volume 14, Issue 6, Page 394-400, June 2022., 2022 Highlights a disintegrin and metalloprotease 10 (ADAM10), a sheddase responsible for the cleavage of a variety of cell surface molecules, has been implicated in the pathogenesis of Alzheimer disease, atherosclerosis, and inflammatory and neoplastic disorders, and systemic ADAM10 concentration may potentially be used as a prognostic biomarker. Our study
Sum Lam +3 more
wiley +1 more source
Journal of Diabetes, Volume 14, Issue 5, Page 306-314, May 2022., 2022 Highlights In this prospective analysis based on multicenter real‐world data, higher‐frequency follow‐up achieved better glycemic control compared with lower‐frequency follow‐up in patients with type 2 diabetes mellitus (T2DM). Furthermore, stratification analysis indicated that metabolic benefits with higher‐frequency follow‐up were predominant in ...
Qiubo Zhao +15 more
wiley +1 more source
Journal of Diabetes, Volume 14, Issue 4, Page 236-246, April 2022., 2022 Highlights Diabetic kidney disease is a progressive disease with the pathology of glomerular damage and loss of podocytes. Sodium glucose cotransporter 2 inhibitors (SGLT2i) can be expected to decrease the amount of podocyte excretion. Male patients receiving SGLT2i have better diabetic kidney disease‐related parameters and podocyturia levels. Abstract
Emre Durcan +13 more
wiley +1 more source
Journal of Diabetes, Volume 14, Issue 3, Page 192-204, March 2022., 2022 Highlights Many proinflammatory cytokines could be decreased after 1 week of intensive insulin therapy using continuous subcutaneous insulin infusion (CSII). This was the first report showing that the cytokines of interleukin‐6 receptor (IL‐6R), tissue inhibitor of metalloproteinase‐2 (TIMP‐2), platelet‐derived growth factor type BB (PDGF‐BB), and ...
Junyu He +6 more
wiley +1 more source
Zhongguo shiyan zhenduanxue, 2012 糖尿病人群与非糖尿病人群相比,有多种蛋白被糖基化。这些蛋白中,糖化血红蛋白（HbA1C）在临床实践中被用作糖尿病患者血糖控制的金标准。HbA1C反映的是患者之前2-3个月的平均血糖浓度,它不但能够反应患者血糖是否得到有效控制,还可以预测患糖尿病并发症的风险 ...
张岩, 谭延国, 亢涛, 郑芳芳
doaj